FDA — authorised 17 June 2009
- Application: BLA125319
- Marketing authorisation holder: NOVARTIS PHARMS
- Local brand name: ILARIS
- Indication: INJECTABLE — SUBCUTANEOUS
- Status: approved
🇺🇸 Ilaris® in United States
FDA authorised Ilaris® on 17 June 2009
Marketing authorisation
Ilaris® in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Ilaris® approved in United States?
Yes. FDA authorised it on 17 June 2009.
Who is the marketing authorisation holder for Ilaris® in United States?
NOVARTIS PHARMS holds the US marketing authorisation.